Claims
- 1. A process for the preparation of vicinal diols comprising asymmetrically dihydroxylating the corresponding olefin in the presence of a cinchona alkaloid using an oxidant in a solvent system consisting of water and at least one of acetone, acetonitrile and t-butanol, in a ratio of water:acetone, water:acetonitrile and water:t-butanol of 1:1 to 1:3, and water:acetone:acetonitrile in a ratio of 1:1:1; at a temperature in the range of −70 to 100° C. for a period in the range of 0.5 to 24 hours, and in the presence of a catalytic amount of a heterogeneous supported osmate catalyst of the general formula (S—NR3)2OsO4.nH2O wherein S is a support, R is an alkyl group, n is the number of water molecules, and recovering the pure vicinal diol by any conventional method.
- 2. A process as in claim 1 wherein the osmium content in the catalyst is in the range of 5 to 30%.
- 3. A process as in claim 1 wherein the support S used has charge balancing anions selected from chloride, bromide, iodide, fluoride, hydroxide and acetate.
- 4. A process as in claim 1 wherein the support is selected from resin or silica.
- 5. A process as in claim 1 wherein R is selected from methyl, ethyl, propyl, butyl and like alkyl groups.
- 6. A process as in claim 1 wherein the amount of supported osmate used in the reaction is 0.01 to 10 mol % of osmium content with respect to the substrate.
- 7. A process as in claim 1 wherein the catalyst is recovered from the reaction system by any conventional process and recycled to the reaction system several times.
- 8. A process as in claim 1 wherein the oxidant used is selected from the group consisting of N-methylmorpholine N-oxide (NMO), trimethylamine N-oxide, hydrogen peroxide, t-butyl hydrogen peroxide, potassium ferricyanide, sodium periodate and molecular oxygen.
- 9. A process as in claim 1 wherein the cinchona alkaloid and derivatives thereof comprise a monomeric and polymeric chiral ligand.
- 10. A process as in claim 9 wherein the chiral ligand is selected from the group consisting of DHQD)2PHAL, (DHQD)2PYR, (DHQD)2AQN, DHQD-OAc, DHQD-CLB, DHQD-PHN, DHQD-MEQ, DHQD-IND and pseudoenantiomeric forms thereof.
RELATED APPLICATIONS
This is a divison of our prior application Ser. No. 09/983,231 filed Oct. 23, 2001 (now U.S. Pat. No. 6,552,234 B1 issued Apr. 22, 2003). This application is also related to our prior applications Ser. No. 10/096,071 filed Mar. 13, 2002 as a CIP of application Ser. No. 09/983,231, now U.S. Pat. No. 6,552,234, and Ser. No. 10/460,468 filed Jun. 13, 2003 as a divisional of application Ser. No. 10/096,071.
US Referenced Citations (3)
Number |
Name |
Date |
Kind |
5227543 |
Sharpless et al. |
Jul 1993 |
A |
5260461 |
Hartung et al. |
Nov 1993 |
A |
6297186 |
Kobayashi |
Oct 2001 |
B1 |
Foreign Referenced Citations (3)
Number |
Date |
Country |
3920917 |
Jan 1991 |
DE |
4210733 |
Oct 1993 |
DE |
WO 9317150 |
Sep 1993 |
WO |